Linsenmeyer 2004.

Methods	Design: Cross‐over RCT Power calculation: NS ITT analysis: no
Participants	Inclusion criteria Setting: patients presenting to outpatient urology rehabilitation clinic; single centre Country: USA Patients with neurogenic bladders secondary to spinal cord injury Number: 37 randomised; 21 analysed Exclusion criteria: NS
Interventions	Treatment group Cranberry tablets: 400 mg standardised tablets Control group Placebo Duration of treatment: 9 weeks (4 weeks on each, plus one week wash out)
Outcomes	Urinary bacterial counts and WBC counts and the combination of bacterial and WBC counts
Notes	Exclusions post randomisation: none Method of obtaining urine sample CSU or MSU Definition of bacteriuria MSU: ≥ 10,000/mL CSU: > 100 cfu/mL
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	NS
Allocation concealment (selection bias)	Unclear risk	NS
Blinding of participants and personnel (performance bias) All outcomes	Low risk	States participants and researchers blinded
Blinding of outcome assessment (detection bias) All outcomes	Low risk	States researchers are blinded, assume outcomes assessors included
Incomplete outcome data (attrition bias) All outcomes	Low risk	All patients accounted for in results and analysis; losses to follow‐up/withdrawals: 16
Selective reporting (reporting bias)	Low risk	Primary outcome is appropriate
Other bias	Unclear risk	Some methods are vague, not a well reported study Source of funding: Eastern Paralyzed Veterans Association